Literature DB >> 19282281

Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance.

Rajat Bhattacharya1, Fernando Cabral.   

Abstract

Vertebrates produce at least seven distinct beta-tubulin isotypes that coassemble into all cellular microtubules. The functional differences among these tubulin isoforms are largely unknown, but recent studies indicate that tubulin composition can affect microtubule properties and cellular microtubule-dependent behavior. One of the isotypes whose incorporation causes the largest change in microtubule assembly is beta5-tubulin. Overexpression of this isotype can almost completely destroy the microtubule network, yet it appears to be required in smaller amounts for normal mitotic progression. Moderate levels of overexpression can also confer paclitaxel resistance. Experiments using chimeric constructs and site-directed mutagenesis now indicate that the hypervariable C-terminal region of beta5 plays no role in these phenotypes. Instead, we demonstrate that two residues found in beta5 (Ser-239 and Ser-365) are each sufficient to inhibit microtubule assembly and confer paclitaxel resistance when introduced into beta1-tubulin; yet the single mutation of residue Ser-239 in beta5 eliminates its ability to confer these phenotypes. Despite the high degree of conservation among beta-tubulin isotypes, mutations affecting residue 365 demonstrate that amino acid substitutions can be context sensitive; i.e. an amino acid change in one isotype will not necessarily produce the same phenotype when introduced into a different isotype. Modeling studies indicate that residue Cys-239 of beta1-tubulin is close to a highly conserved Cys-354 residue suggesting the possibility that disulfide formation could play a significant role in the stability of microtubules formed with beta1- but not with beta5-tubulin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282281      PMCID: PMC2676035          DOI: 10.1074/jbc.M900167200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance.

Authors:  M L Gonzalez-Garay; L Chang; K Blade; D R Menick; F Cabral
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

2.  The C-terminus of tubulin increases cytoplasmic dynein and kinesin processivity.

Authors:  Z Wang; M P Sheetz
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

3.  Refined structure of alpha beta-tubulin at 3.5 A resolution.

Authors:  J Löwe; H Li; K H Downing; E Nogales
Journal:  J Mol Biol       Date:  2001-11-09       Impact factor: 5.469

4.  A mechanism for microtubule depolymerization by KinI kinesins.

Authors:  Carolyn A Moores; Ming Yu; Jun Guo; Christophe Beraud; Roman Sakowicz; Ronald A Milligan
Journal:  Mol Cell       Date:  2002-04       Impact factor: 17.970

5.  XKCM1 acts on a single protofilament and requires the C terminus of tubulin.

Authors:  Hanspeter Niederstrasser; Hani Salehi-Had; Eugene C Gan; Claire Walczak; Eva Nogales
Journal:  J Mol Biol       Date:  2002-02-22       Impact factor: 5.469

Review 6.  The role of beta-tubulin isotypes in resistance to antimitotic drugs.

Authors:  C A Burkhart; M Kavallaris; S Band Horwitz
Journal:  Biochim Biophys Acta       Date:  2001

7.  beta-Tubulin C354 mutations that severely decrease microtubule dynamics do not prevent nuclear migration in yeast.

Authors:  Mohan L Gupta; Claudia J Bode; Douglas A Thrower; Chad G Pearson; Kathy A Suprenant; Kerry S Bloom; Richard H Himes
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

8.  Detection of disulfide bonds in bovine brain tubulin and their role in protein folding and microtubule assembly in vitro: a novel disulfide detection approach.

Authors:  A R Chaudhuri; I A Khan; R F Ludueña
Journal:  Biochemistry       Date:  2001-07-31       Impact factor: 3.162

9.  Overexpression of class I, II or IVb beta-tubulin isotypes in CHO cells is insufficient to confer resistance to paclitaxel.

Authors:  K Blade; D R Menick; F Cabral
Journal:  J Cell Sci       Date:  1999-07       Impact factor: 5.285

10.  Engineering the processive run length of the kinesin motor.

Authors:  K S Thorn; J A Ubersax; R D Vale
Journal:  J Cell Biol       Date:  2000-11-27       Impact factor: 10.539

View more
  15 in total

1.  Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle.

Authors:  Davide Randazzo; Umara Khalique; Joseph J Belanto; Aster Kenea; Dana M Talsness; John T Olthoff; Michelle D Tran; Kristien J Zaal; Katherine Pak; Iago Pinal-Fernandez; Andrew L Mammen; Dan Sackett; James M Ervasti; Evelyn Ralston
Journal:  Hum Mol Genet       Date:  2019-04-01       Impact factor: 6.150

Review 2.  New insights into mechanisms of resistance to microtubule inhibitors.

Authors:  Anutosh Ganguly; Fernando Cabral
Journal:  Biochim Biophys Acta       Date:  2011-06-29

3.  Proteomics of cancer cell lines resistant to microtubule-stabilizing agents.

Authors:  Jakob Albrethsen; Ruth H Angeletti; Susan Band Horwitz; Chia-Ping Huang Yang
Journal:  Mol Cancer Ther       Date:  2013-11-19       Impact factor: 6.261

Review 4.  Microtubule-binding agents: a dynamic field of cancer therapeutics.

Authors:  Charles Dumontet; Mary Ann Jordan
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

5.  Prognostic biomarkers for HNSCC using quantitative real-time PCR and microarray analysis: β-tubulin isotypes and the p53 interactome.

Authors:  Sharon Lobert; Mary E Graichen; Robert D Hamilton; Karen T Pitman; Michael R Garrett; Chindo Hicks; Tejaswi Koganti
Journal:  Cytoskeleton (Hoboken)       Date:  2014-11-22

6.  Characterization of a human βV-tubulin antibody and expression of this isotype in normal and malignant human tissue.

Authors:  Suzan K Chao; Yihong Wang; Pascal Verdier-Pinard; Chia-Ping H Yang; Lingling Liu; Alicia Rodriguez-Gabin; Hayley M McDaid; Susan Band Horwitz
Journal:  Cytoskeleton (Hoboken)       Date:  2012-07-02

7.  Random mutagenesis of β-tubulin defines a set of dispersed mutations that confer paclitaxel resistance.

Authors:  Shanghua Yin; Changqing Zeng; Malathi Hari; Fernando Cabral
Journal:  Pharm Res       Date:  2012-06-06       Impact factor: 4.200

8.  Class V β-tubulin alters dynamic instability and stimulates microtubule detachment from centrosomes.

Authors:  Rajat Bhattacharya; Hailing Yang; Fernando Cabral
Journal:  Mol Biol Cell       Date:  2011-02-02       Impact factor: 4.138

Review 9.  Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents.

Authors:  Katherine M Moxley; D Scott McMeekin
Journal:  Oncologist       Date:  2010-10-07

10.  βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer.

Authors:  D C Christoph; S Kasper; T C Gauler; C Loesch; M Engelhard; D Theegarten; C Poettgen; R Hepp; A Peglow; H Loewendick; S Welter; G Stamatis; F R Hirsch; M Schuler; W E E Eberhardt; J Wohlschlaeger
Journal:  Br J Cancer       Date:  2012-07-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.